CHI3L1 and androgen insensitivity syndrome: However, considering the rapid elevation and subsequent decrease in YKL-40 within 3 days of AIS and the use of exclusion criteria, including acute infection and specified comorbidities, AIS seems to be the major contributor to the observed difference between AIS patients and controls, especially on D2.